SCHEMBL8803281

SCHEMBL8803281

CCOC(=O)C(CCCNC(=O)OC(C)(C)C)(OCCc1ccccc1)C(=O)OCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
SIGMAR1 Q99720 3/20 0.49
IDO1 P14902 1/20 0.49
CTSK P43235 2/20 0.44
NPSR1 Q6W5P4 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
PTPRB P23467 1/20 0.43
SYK P43405 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8799056 0.95 SIGMAR1 (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8329540 0.90 IDO1 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8798252 0.88 CYP3A4 (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8799940 0.83 CTSK (0.42) IDO1CTSKCA1CA2PTPRB
SCHEMBL8798966 0.83 PTPRB (0.40) PTPRBPOLBKDM4ELMNAALDH1A1
SCHEMBL8633540 0.82 IDO1 (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8798754 0.81 CYP3A4 (0.57) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8331034 0.80 TDP1 (0.44) IDO1CA1CA2PTPRBHTT
SCHEMBL8800128 0.80 CA12 (0.47) CA1CA2MAPT
SCHEMBL8800029 0.80 KEAP1 (0.42) IDO1NPSR1CA1CA2PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed